A new study suggests that drugs like Ozempic and Mounjaro may reduce dementia risk. Researchers at the University of Galway found a 45% lower risk in patients taking these medications. The drugs may ...

Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.

The popular diabetes and weight-loss drug semaglutide may lower the risk of dementia when taken by Type 2 diabetes patients, new research from the Case Western Reserve School ...

A new scientific study has found that weight loss jabs such as Mounjaro and Ozempic can help protect against serious health ...

A new study of 60,000 people around the world is shedding light on the possible brain health benefits of popular weight-loss ...

Neuroscientist Sabina Brennan encourages caregivers to live in the moment and notice the happy experiences they share with ...

Researchers found that the active ingredient in Ozempic may lower the risk of dementia in people with type 2 diabetes.

Weight-loss injections, including popular drugs like Wegovy and Mounjaro, may offer a protective shield against serious ...

Novo Nordisk reportedly failed to pay its annual fees to maintain the patent rights in Canada, opening the door to cheaper ...

For people who are obese and have type 2 diabetes, using Ozempic and other GLP-1 agonist drugs cuts the all-cause mortality rate by 30%, according to a new Use of GLP-1 agonists also cut the risk that ...

Over seven years, those taking medication such as Ozempic and Mounjaro - were less likely to develop these brain issues or die prematurely. But Edinburgh University's Professor Tara Spires-Jones told ...

A man taking Mounjaro as a weight loss drug has explained one of the side effects he's suffering from which 'nobody talks ...